A Phase II Trial of Dasatinib to Treat Women With Stage IV or Inoperable Stage III Advanced Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 16 Jul 2013
At a glance
- Drugs Dasatinib (Primary)
- Indications Advanced breast cancer
- Focus Biomarker; Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 13 Jun 2011 Actual end date (May 2011) added as reported by ClinicalTrials.gov.
- 13 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.